Your browser doesn't support javascript.
loading
Plasma membrane Ca2+ pump isoform 4 function in cell migration and cancer metastasis.
Naffa, Randa; Hegedus, Luca; Hegedus, Tamás; Tóth, Sarolta; Papp, Béla; Tordai, Attila; Enyedi, Ágnes.
Afiliación
  • Naffa R; Molecular Biology Research Laboratory, School of Medicine, The University of Jordan, Amman, Jordan.
  • Hegedus L; Department of Thoracic Surgery, Ruhrlandklinik, University Clinic Essen, Essen, Germany.
  • Hegedus T; Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary.
  • Tóth S; ELKH-SE Biophysical Virology Research Group, Eötvös Loránd Research Network, Budapest, Hungary.
  • Papp B; Department of Transfusion Medicine, Semmelweis University, Budapest, Hungary.
  • Tordai A; Institut National de la Santé et de la Recherche Médicale, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Paris, France.
  • Enyedi Á; Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Université de Paris, Paris, France.
J Physiol ; 602(8): 1551-1564, 2024 Apr.
Article en En | MEDLINE | ID: mdl-36876504
The Ca2+ ion is a universal second messenger involved in many vital physiological functions including cell migration and development. To fulfil these tasks the cytosolic Ca2+ concentration is tightly controlled, and this involves an intricate functional balance between a variety of channels and pumps of the Ca2+ signalling machinery. Among these proteins, plasma membrane Ca2+ ATPases (PMCAs) represent the major high-affinity Ca2+ extrusion systems in the cell membrane that are effective in maintaining free Ca2+ concentration at exceedingly low cytosolic levels, which is essential for normal cell function. An imbalance in Ca2+ signalling can have pathogenic consequences including cancer and metastasis. Recent studies have highlighted the role of PMCAs in cancer progression and have shown that a particular variant, PMCA4b, is downregulated in certain cancer types, causing delayed attenuation of the Ca2+ signal. It has also been shown that loss of PMCA4b leads to increased migration and metastasis of melanoma and gastric cancer cells. In contrast, an increased PMCA4 expression has been reported in pancreatic ductal adenocarcinoma that coincided with increased cell migration and shorter patient survival, suggesting distinct roles of PMCA4b in various tumour types and/or different stages of tumour development. The recently discovered interaction of PMCAs with basigin, an extracellular matrix metalloproteinase inducer, may provide further insights into our understanding of the specific roles of PMCA4b in tumour progression and cancer metastasis.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Physiol Año: 2024 Tipo del documento: Article País de afiliación: Jordania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Physiol Año: 2024 Tipo del documento: Article País de afiliación: Jordania